PL1740164T3 - Statyny do leczenia nadciśnienia śródgałkowego i jaskry - Google Patents
Statyny do leczenia nadciśnienia śródgałkowego i jaskryInfo
- Publication number
- PL1740164T3 PL1740164T3 PL05738648T PL05738648T PL1740164T3 PL 1740164 T3 PL1740164 T3 PL 1740164T3 PL 05738648 T PL05738648 T PL 05738648T PL 05738648 T PL05738648 T PL 05738648T PL 1740164 T3 PL1740164 T3 PL 1740164T3
- Authority
- PL
- Poland
- Prior art keywords
- statins
- glaucoma
- treatment
- ocular hypertension
- coa reductase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56546904P | 2004-04-26 | 2004-04-26 | |
EP05738648A EP1740164B1 (en) | 2004-04-26 | 2005-04-25 | Statins for the treatment of ocular hypertension and glaucoma |
PCT/US2005/014255 WO2005105069A1 (en) | 2004-04-26 | 2005-04-25 | Statins for the treatment of ocular hypertension and glaucoma |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1740164T3 true PL1740164T3 (pl) | 2009-01-30 |
Family
ID=34966865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05738648T PL1740164T3 (pl) | 2004-04-26 | 2005-04-25 | Statyny do leczenia nadciśnienia śródgałkowego i jaskry |
Country Status (20)
Country | Link |
---|---|
US (2) | US20050239871A1 (pl) |
EP (1) | EP1740164B1 (pl) |
JP (1) | JP2007534699A (pl) |
KR (2) | KR20110091600A (pl) |
CN (1) | CN1946384B (pl) |
AT (1) | ATE404189T1 (pl) |
AU (1) | AU2005237543B2 (pl) |
BR (1) | BRPI0510245A (pl) |
CA (1) | CA2560167A1 (pl) |
CY (1) | CY1108490T1 (pl) |
DE (1) | DE602005008935D1 (pl) |
DK (1) | DK1740164T3 (pl) |
ES (1) | ES2311986T3 (pl) |
HK (1) | HK1102913A1 (pl) |
MX (1) | MXPA06012225A (pl) |
PL (1) | PL1740164T3 (pl) |
PT (1) | PT1740164E (pl) |
SI (1) | SI1740164T1 (pl) |
WO (1) | WO2005105069A1 (pl) |
ZA (1) | ZA200607988B (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8415364B2 (en) * | 2003-11-26 | 2013-04-09 | Duke University | Method of preventing or treating glaucoma |
KR20080082618A (ko) * | 2005-12-16 | 2008-09-11 | 알콘, 인코퍼레이티드 | Alk5 조절제를 사용한 안압의 조절 |
AU2007245410A1 (en) | 2006-04-26 | 2007-11-08 | Rosemont Pharmaceuticals Ltd | Liquid oral compositions |
US20090202524A1 (en) * | 2007-10-31 | 2009-08-13 | Alcon Research, Ltd. | Pai-1 expression and activity inhibitors for the treatment of ocular disorders |
ES2330184B1 (es) * | 2008-06-03 | 2010-07-05 | Neuron Biopharma, S.A. | Uso de estatinas como anticonvulsivantes, antiepilepticos y neuroprotectores. |
US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
US8299079B2 (en) | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
CN102093984B (zh) * | 2010-11-23 | 2012-07-04 | 清华大学 | 一种杂合酶P450sca2-BMR及其编码基因与应用 |
AU2013214693B2 (en) * | 2012-02-02 | 2017-02-23 | Kenneth Gek-Jin OOI | Improvements in tear film stability |
GB201611782D0 (en) * | 2016-07-06 | 2016-08-17 | Optibiotix Ltd | Composition |
US10696638B2 (en) | 2017-12-26 | 2020-06-30 | Industrial Technology Research Institute | Compounds for inhibiting AGC kinase and pharmaceutical compositions comprising the same |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2534580A1 (fr) * | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
FR2585708B1 (fr) * | 1985-07-31 | 1989-07-07 | Sanofi Sa | Derives aminoalcools peptidiques inhibiteurs de la resine et des proteases acides, leur procede de preparation et leur application en therapeutique |
US5151444B1 (en) * | 1987-09-18 | 1999-07-06 | R Tech Ueno Ltd | Ocular hypotensive agents |
EP0569046B1 (en) * | 1988-09-06 | 2002-11-13 | Pharmacia Aktiebolag | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
FR2647675B1 (fr) * | 1989-06-05 | 1994-05-20 | Sanofi | Utilisation d'un derive de la statine dans le traitement des affections oculaires |
JPH04243835A (ja) * | 1990-08-29 | 1992-08-31 | Pfizer Inc | 高眼圧症又は緑内障治療用薬剤組成物及び治療方法 |
US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
US5599535A (en) * | 1995-06-07 | 1997-02-04 | Regents Of The University Of California | Methods for the cyto-protection of the trabecular meshwork |
US6586425B2 (en) * | 1996-02-21 | 2003-07-01 | Wisconsin Alumni Research Foundation | Cytoskeletal active agents for glaucoma therapy |
US6569461B1 (en) * | 1999-03-08 | 2003-05-27 | Merck & Co., Inc. | Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors |
WO2002024194A2 (en) * | 2000-09-19 | 2002-03-28 | Novimmune S.A. | Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
US20030065020A1 (en) * | 2001-07-13 | 2003-04-03 | Catharine Gale | Treatment of macular degeneration |
US20030195167A1 (en) * | 2002-04-15 | 2003-10-16 | Kowa Co., Ltd. | PTX3-gene expression inhibitor |
JP2004149480A (ja) * | 2002-10-31 | 2004-05-27 | Saisentan Igaku Kenkyusho:Kk | 経口又は経皮投与用の眼科疾患治療剤 |
AU2004247627A1 (en) * | 2003-05-16 | 2004-12-23 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
US20040248972A1 (en) * | 2003-05-16 | 2004-12-09 | Ambit Biosciences Corporation | Compounds and uses thereof |
JP2006526640A (ja) * | 2003-05-30 | 2006-11-24 | コンビナトアールエックス インコーポレーティッド | 新生物を治療するための併用治療 |
US8415364B2 (en) * | 2003-11-26 | 2013-04-09 | Duke University | Method of preventing or treating glaucoma |
US20090202524A1 (en) * | 2007-10-31 | 2009-08-13 | Alcon Research, Ltd. | Pai-1 expression and activity inhibitors for the treatment of ocular disorders |
-
2005
- 2005-04-25 EP EP05738648A patent/EP1740164B1/en not_active Not-in-force
- 2005-04-25 PT PT05738648T patent/PT1740164E/pt unknown
- 2005-04-25 US US11/114,512 patent/US20050239871A1/en not_active Abandoned
- 2005-04-25 CA CA002560167A patent/CA2560167A1/en not_active Abandoned
- 2005-04-25 AU AU2005237543A patent/AU2005237543B2/en not_active Ceased
- 2005-04-25 PL PL05738648T patent/PL1740164T3/pl unknown
- 2005-04-25 KR KR1020117018000A patent/KR20110091600A/ko not_active Application Discontinuation
- 2005-04-25 DE DE602005008935T patent/DE602005008935D1/de active Active
- 2005-04-25 ES ES05738648T patent/ES2311986T3/es active Active
- 2005-04-25 SI SI200530460T patent/SI1740164T1/sl unknown
- 2005-04-25 ZA ZA200607988A patent/ZA200607988B/xx unknown
- 2005-04-25 WO PCT/US2005/014255 patent/WO2005105069A1/en active Application Filing
- 2005-04-25 JP JP2007509736A patent/JP2007534699A/ja active Pending
- 2005-04-25 CN CN2005800130061A patent/CN1946384B/zh not_active Expired - Fee Related
- 2005-04-25 AT AT05738648T patent/ATE404189T1/de active
- 2005-04-25 DK DK05738648T patent/DK1740164T3/da active
- 2005-04-25 BR BRPI0510245-6A patent/BRPI0510245A/pt not_active IP Right Cessation
- 2005-04-25 MX MXPA06012225A patent/MXPA06012225A/es active IP Right Grant
-
2006
- 2006-11-15 KR KR1020067023958A patent/KR101071192B1/ko not_active IP Right Cessation
-
2007
- 2007-07-10 HK HK07107383.3A patent/HK1102913A1/xx not_active IP Right Cessation
-
2008
- 2008-11-07 CY CY20081101271T patent/CY1108490T1/el unknown
-
2010
- 2010-11-08 US US12/941,639 patent/US20110098314A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2560167A1 (en) | 2005-11-10 |
BRPI0510245A (pt) | 2007-10-23 |
SI1740164T1 (sl) | 2009-02-28 |
CN1946384B (zh) | 2011-04-20 |
WO2005105069A1 (en) | 2005-11-10 |
MXPA06012225A (es) | 2007-01-31 |
DE602005008935D1 (de) | 2008-09-25 |
DK1740164T3 (da) | 2008-11-10 |
ATE404189T1 (de) | 2008-08-15 |
EP1740164A1 (en) | 2007-01-10 |
US20110098314A1 (en) | 2011-04-28 |
KR20110091600A (ko) | 2011-08-11 |
CY1108490T1 (el) | 2014-04-09 |
AU2005237543B2 (en) | 2011-02-10 |
CN1946384A (zh) | 2007-04-11 |
EP1740164B1 (en) | 2008-08-13 |
ES2311986T3 (es) | 2009-02-16 |
AU2005237543A1 (en) | 2005-11-10 |
PT1740164E (pt) | 2008-10-21 |
KR101071192B1 (ko) | 2011-10-10 |
HK1102913A1 (en) | 2007-12-07 |
KR20070007932A (ko) | 2007-01-16 |
JP2007534699A (ja) | 2007-11-29 |
US20050239871A1 (en) | 2005-10-27 |
ZA200607988B (en) | 2007-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1102913A1 (en) | Statins for the treatment of ocular hypertension and glaucoma | |
WO2006066103A3 (en) | Ophthalmic implant for treatment of glaucoma | |
EA200701134A1 (ru) | Средство для профилактики или лечения глаукомы | |
WO2003092584A3 (en) | Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies | |
TW200733964A (en) | (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating rho kinase-mediated diseases and conditions | |
WO2006071548A3 (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases | |
WO2005002520A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2006044425A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
HK1082668A1 (en) | Remedies for glomerular diseases | |
WO2003072066A3 (en) | Compositions and methods for the treatment of glaucoma and ocular hypertension | |
WO2002009702A8 (en) | Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure | |
ATE359794T1 (de) | 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes | |
CA2505086A1 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2005020917A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
AU4672300A (en) | Biochemical methods that eliminate corneal scars, opacification and haze | |
WO2004043354A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2006020003A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
EP1251862A4 (en) | ORTHALMOLOGICAL COMPOSITIONS FOR THE TREATMENT OF OCULAR HYPERTENSION | |
MXPA04006029A (es) | Derivados novedosos de benzofuranimidazolina y benzodifuranimidazolina y su uso para el tratamiento de glaucoma. | |
MXPA04001255A (es) | Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma. | |
WO2002060339A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2004087051A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2003077845A3 (en) | Compositions and methods for treating glaucoma and ocular hypertension |